HeartBeam Launches $25M At-The-Market Offering Amid Going Concern Warning
BEAT is trading near its 52-week low of $0.481 (5.3% above the low).
Summary
HeartBeam entered into an at-the-market equity offering sales agreement for up to $25 million in common stock. The company's Q2 2026 filing showed a $5.0 million net loss, $8.7 million in cash, and a going concern warning, so this ATM provides a funding source but will dilute existing shareholders. The stock trades at $0.507, below the Nasdaq $1.00 minimum bid requirement, adding urgency to the capital raise. This follows the 8-K filed earlier today disclosing the same agreement, and the company already has a $100 million universal shelf registration on file. The offering is highly dilutive relative to the company's $27.7 million market cap.
At the time of this announcement, BEAT was trading at $0.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $27.7M. The 52-week trading range was $0.48 to $4.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.